+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Vector Manufacturing Market Report by Type, Disease, Application, End User, and Region 2024-2032

  • PDF Icon

    Report

  • 138 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5546981
Description Jump to:
The global viral vector manufacturing market size reached US$ 1.20 billion in 2023. Looking forward, the publisher expects the market to reach US$ 7.68 billion by 2032, exhibiting a growth rate (CAGR) of 22.9% during 2023-2032.

A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It is used to replace defective genes for curing genetic disorders and express and present pathogenic antigens for generating an immune response by mimicking a natural infection. It is widely employed in oncolytic therapies to target and kill tumor cells. Besides this, as it assists in treating different diseases, such as heart defects, metabolic diseases, and neurodegenerative disorders, it finds extensive applications in life science research, gene therapy and vaccinology. At present, there is a rise in viral vector manufacturing on account of the rising prevalence of genetic disorders due to a combination of gene mutations and damaged chromosomes in the body.

Viral Vector Manufacturing Market Trends:

The increasing cancer patients due to the rising alcohol consumption and sedentary lifestyles of individuals represents one of the key factors contributing to the growth of the market. In addition, there is a rise in the number of clinical studies undertaken on viral vectors across the globe. This, along with the growing utilization of viral vectors in novel drug delivery, is positively influencing the market. Besides this, they are efficient carriers of virus-disabling sequences and are used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). Additionally, governments of several countries are launching campaigns to generate awareness about viral vector vaccines among individuals. They are also improving the regulatory environment via changes, such as fast-track approval processes. Furthermore, key market players are extensively investing in capacity expansion for manufacturing activities around the world. These players are also indulging in mergers and acquisitions (M&A), which is projected to increase their overall sales and profitability.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global viral vector manufacturing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, disease, application and end user.

Breakup by Type:

Adenoviral Vectors
Adeno-associated Viral Vectors
Lentiviral Vectors
Retroviral Vectors
Others

Breakup by Disease:

Cancer
Genetic Disorders
Infectious Diseases
Others

Breakup by Application:

Gene Therapy
Vaccinology

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies
Research Institutes

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.

Key Questions Answered in This Report

1. What was the size of the global viral vector manufacturing market in 2023?
2. What is the expected growth rate of the global viral vector manufacturing market during 2024-2032?
3. What has been the impact of COVID-19 on the global viral vector manufacturing market?
4. What are the key factors driving the global viral vector manufacturing market?
5. What is the breakup of the global viral vector manufacturing market based on the type?
6. What is the breakup of the global viral vector manufacturing market based on the disease?
7. What is the breakup of the global viral vector manufacturing market based on the application?
8. What are the key regions in the global viral vector manufacturing market?
9. Who are the key players/companies in the global viral vector manufacturing market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Viral Vector Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Adenoviral Vectors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Adeno-associated Viral Vectors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Lentiviral Vectors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Retroviral Vectors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Disease
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Genetic Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Application
8.1 Gene Therapy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Vaccinology
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical and Biopharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Cognate BioServices Inc. (Charles River Laboratories International Inc.)
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 F. Hoffmann-La Roche AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.3 FinVector Oy
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 FUJIFILM Holdings Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Kaneka Eurogentec S.A. (Kaneka Corporation)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Lonza Group AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Biomedica plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 REGENXBIO Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 uniQure N.V.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
List of Figures
Figure 1: Global: Viral Vector Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Viral Vector Manufacturing Market: Breakup by Type (in %), 2023
Figure 5: Global: Viral Vector Manufacturing Market: Breakup by Disease (in %), 2023
Figure 6: Global: Viral Vector Manufacturing Market: Breakup by Application (in %), 2023
Figure 7: Global: Viral Vector Manufacturing Market: Breakup by End User (in %), 2023
Figure 8: Global: Viral Vector Manufacturing Market: Breakup by Region (in %), 2023
Figure 9: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Viral Vector Manufacturing (Retroviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Viral Vector Manufacturing (Retroviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Viral Vector Manufacturing (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Viral Vector Manufacturing (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Viral Vector Manufacturing (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Viral Vector Manufacturing (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Viral Vector Manufacturing (Genetic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Viral Vector Manufacturing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Viral Vector Manufacturing (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Viral Vector Manufacturing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Viral Vector Manufacturing (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Viral Vector Manufacturing (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Viral Vector Manufacturing (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Viral Vector Manufacturing (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Viral Vector Manufacturing (Vaccinology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Viral Vector Manufacturing (Vaccinology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Viral Vector Manufacturing (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Viral Vector Manufacturing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Canada: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Canada: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Asia-Pacific: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Asia-Pacific: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: China: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: China: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Japan: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Japan: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: India: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: India: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South Korea: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South Korea: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Australia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Australia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Indonesia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Indonesia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Europe: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Europe: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Germany: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Germany: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: France: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: France: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: United Kingdom: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: United Kingdom: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Italy: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Italy: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Russia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Russia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Latin America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Latin America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Brazil: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Brazil: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Mexico: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Mexico: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Middle East and Africa: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Middle East and Africa: Viral Vector Manufacturing Market: Breakup by Country (in %), 2023
Figure 83: Middle East and Africa: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Viral Vector Manufacturing Industry: SWOT Analysis
Figure 85: Global: Viral Vector Manufacturing Industry: Value Chain Analysis
Figure 86: Global: Viral Vector Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Viral Vector Manufacturing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Viral Vector Manufacturing Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Viral Vector Manufacturing Market Forecast: Breakup by Disease (in Million US$), 2024-2032
Table 4: Global: Viral Vector Manufacturing Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Viral Vector Manufacturing Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Viral Vector Manufacturing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Viral Vector Manufacturing Market: Competitive Structure
Table 8: Global: Viral Vector Manufacturing Market: Key Players

Companies Mentioned

  • Cognate BioServices Inc. (Charles River Laboratories International Inc.)
  • F. Hoffmann-La Roche AG
  • FinVector Oy
  • FUJIFILM Holdings Corporation
  • Kaneka Eurogentec S.A. (Kaneka Corporation)
  • Lonza Group AG
  • Merck KGaA
  • Oxford Biomedica plc
  • REGENXBIO Inc.
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages138
PublishedJuly 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 1200.1 Million
Forecasted Market Value ( USD ) by 2032 $ 7681.6 Million
Compound Annual Growth Rate22.9%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Viral Vector Manufacturing Market Report and Forecast 2024-2032 - Product Image

Viral Vector Manufacturing Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034 - Product Image

Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034

  • Report
  • 408 Pages
  • Global
From
Viral Vector Manufacturing Market by Type, Disease, Application - Global Forecast 2025-2030 - Product Image

Viral Vector Manufacturing Market by Type, Disease, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Viral Vector Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Viral Vector Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Viral Vector & Plasmid DNA Manufacturing Market by Type, Cell Line, Transfection, Indication, Workflow, Application, End User - Global Forecast 2025-2030 - Product Image

Viral Vector & Plasmid DNA Manufacturing Market by Type, Cell Line, Transfection, Indication, Workflow, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.